Back to today’s briefing

Story perspectives

Metformin: Promising New Ally Against Colon Cancer

5/8/2025

49 3

Summary

Story summary

Metformin, a common diabetes drug, is emerging as a hopeful ally in the fight against colon cancer, as revealed by researchers at The Ohio State University. Initial findings indicate it may slow the growth of cancer cells, especially those with KRAS mutations. With its low cost and proven safety, metformin could be a game-changer in cancer treatment.

1 of 1

Story summary

Metformin, a common diabetes drug, is emerging as a hopeful ally in the fight against colon cancer, as revealed by researchers at The Ohio State University. Initial findings indicate it may slow the growth of cancer cells, especially those with KRAS mutations. With its low cost and proven safety, metformin could be a game-changer in cancer treatment.